SAN DIEGO (Reuters) - A single treatment with gene therapy, an experimental technique for fixing faulty genes, has been shown for the first time to boost output of a vital blood clotting factor, possibly offering a long-term solution for people with hemophilia B. Researchers said the same technology was also being studied as a treatment for hemophilia A, the far more common type of the inherited bleeding disorder. "It is a technique for potentially permanently curing patients," said Dr. ...
0 comments:
Post a Comment